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Although traditional roles ascribed to myelinating glial cells are
structural and supportive, the importance of compact myelin
for proper functioning of the nervous system can be inferred
from mutations in myelin proteins and neuropathologies asso-
ciated with loss of myelin. Myelinating Schwann cells are
known to affect local properties of peripheral axons (de Waegh
et al., 1992), but little is known about effects of oligodendro-
cytes on CNS axons. The shiverer mutant mouse has a deletion
in the myelin basic protein gene that eliminates compact myelin
in the CNS. In shiverer mice, both local axonal features like
phosphorylation of cytoskeletal proteins and neuronal
perikaryon functions like cytoskeletal gene expression are al-
tered. This leads to changes in the organization and composi-
tion of the axonal cytoskeleton in shiverer unmyelinated axons
relative to age-matched wild-type myelinated fibers, although
connectivity and patterns of neuronal activity are comparable.
Remarkably, transgenic shiverer mice with thin myelin sheaths
display an intermediate phenotype indicating that CNS neurons
are sensitive to myelin sheath thickness. These results indicate
that formation of a normal compact myelin sheath is required
for normal maturation of the neuronal cytoskeleton in large CNS
neurons.
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The first description of non-neuronal cells in nervous tissue is
generally attributed to Virchow (1846), when he described mate-
rial that filled spaces between nerve elements. For much of the
last century and a half, the operational definition of glia for many
neuroscientists was not much more detailed. Although a substan-
tial literature has accrued on glia (Kettenmann and Ransom,
1995), the roles of glia in the nervous system remain less well
defined than those of neurons. Contemporary neuroscience texts
list glial functions variously as providing structural support for
neurons, formation of myelin sheaths for insulating large axons,
buffering of ionic environment and clearance of neurotransmit-
ters, and poorly defined nutritive activities. However, recent
evidence suggests a wider range of glial activities affecting neu-
ronal function. In particular, cell–cell communication between
neurons and glia may be more extensive than previously thought.
Given the intimate relationship between myelinating glia and
their associated axons, the potential of myelin-forming glia to
affect neuronal properties is considerable.
Analysis of axons in mice with mutations affecting myelination
has proven particularly instructive. For example, Trembler mice
are characterized by demyelination of large axons in the periph-
eral nervous system (PNS) (Low and McLeod, 1975) with no
significant effect on myelination of CNS axons. Trembler is a
dominant mutation with several alleles, all associated with alter-
ations in a peripheral myelin protein, PMP22 (Suter et al.,
1992a,b). PMP22 is also defective in Charcot-Marie-Tooth type
IA peripheral neuropathy (Lupski et al., 1991), making Trembler
a homolog of the human disease. Affected PNS axons undergo
continuing cycles of myelination and demyelination, resulting in a
high percentage of large axons with little or no compact myelin
(Low, 1976a,b).
Studies on Trembler mouse nerves revealed significant changes
in large peripheral axons associated with demyelination. Both
organization and dynamics of the axonal cytoskeleton in PNS
nerves were altered by demyelination. Remarkably, most changes
were restricted to axon segments without compact myelin
(Aguayo et al., 1977; de Waegh et al., 1992). Local alterations in
axons included rates of slow axonal transport (de Waegh and
Brady, 1990; de Waegh et al., 1992), phosphorylation of neuro-
filament and microtubule protein (de Waegh et al., 1992; Kirk-
patrick and Brady, 1994), and neurofilament density (de Waegh
and Brady, 1991; de Waegh et al., 1992). Subsequent studies on
normal myelinated fibers and other models of PNS hypomyelina-
tion confirmed that myelination locally influences neurofilament
density and phosphorylation (Mata et al., 1992; Cole et al., 1994;
Hsieh et al., 1994). Gaps in myelin as small as a PNS node of
Ranvier produce dramatic, highly localized changes in axon cy-
toskeletal organization (de Waegh, 1990; Mata et al., 1992; Hsieh
et al., 1994) and neurofilament phosphorylation (Mata et al.,
1992; Hsieh et al., 1994). This led to the proposal that myelinating
glia play a primary role in regulation of axon cytoskeletal orga-
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nization and targeting of axonal proteins like sodium channels
(de Waegh et al., 1992; Brady, 1993).
Demyelination-induced changes in PNS axons raised questions
about effects of myelination on CNS axons. CNS myelin is pro-
duced by oligodendrocytes rather than Schwann cells, and some
functions served by Schwann cells in the PNS may be filled by
astrocytes in the CNS. The protein composition (Morell et al.,
1994) and fine structure (Raine, 1984; Peters et al., 1991) of CNS
myelin differ from PNS myelin. Because central myelination is
unperturbed in Trembler, we analyzed a different mouse mutant.
Shiverer is a recessive mutation with a more severe phenotype
than Trembler. Shiverer mutant mice not only develop a severe
tremor in early postnatal development, but they have a mean life
span of ;100 d (Chernoff, 1981). Shiverer mice lack compact
CNS myelin (Readhead and Hood, 1990) because of deletion of
coding regions in the myelin basic protein (MBP) gene (Roach et
al., 1985), a major structural protein of CNS myelin (Campagnoni
and Macklin, 1988). Although MBP is expressed in PNS myelin
as well, two PNS-specific proteins, P0 and P2, appear to have
functional overlap with MBP so PNS myelination is near normal
(Rosenbluth, 1980).
Unlike Trembler where PNS axons are subject to a constant
cycle of myelination and demyelination, the absence of a major
structural protein for myelin means that shiverer CNS axons
never see normal myelin. Studies with various mouse strains
indicate that MBP expression can limit myelin sheath formation
(Shine et al., 1992), and transgenic mice expressing intermediate
levels of MBP in a shiverer background (Readhead et al., 1987)
have been generated. Mice homozygous for the MBP transgene
express only 25% of wild-type MBP levels resulting in thin
compact myelin with few lamellae. However, this is sufficient to
suppress tremors and increase life spans to near wild-type, effect-
ing a “cure” of this neurogenetic disease (Readhead et al., 1987).
Availability of shiverer (shi) and transgenic mice homozygous for
the MBP transgene (MBP/MBP) permitted evaluation of com-
pact myelin effects on CNS neurons.
A wide range of neuronal parameters were altered in shiverer
mouse CNS tissues. These included differences in slow axonal
transport, cytoskeletal composition, posttranslational modifica-
tion of cytoskeletal proteins, axon caliber, and neuronal gene
expression. In each case, neurons in the shiverer mouse exhibited
characteristics similar to early postnatal axons before myelina-
tion. Remarkably, analysis of these same parameters in the CNS
of MBP/MBP mice with minimal tremor and normal life spans
revealed a phenotype with features of both wild-type and shiv-
erer. Rates of slow axonal transport and levels of NFM neuro-
filament protein in axons were comparable to wild-type in MBP/
MBP mice, whereas other aspects of the axonal cytoskeleton and
neuronal gene expression in MBP/MBP mice were more like
shiverer.
These results demonstrate that myelinating glia in the CNS
profoundly influence associated neurons and suggest an extensive
dialogue between oligodendrocytes and axons. Myelinating glia
influence both local axonal features like posttranslational modi-
fication of cytoskeletal proteins as well as cytoskeletal gene ex-
pression in the neuronal perikaryon. Incomplete recovery of
normal phenotype in neurons of MBP/MBP mice implies that
multiple regulatory pathways exist, which are somehow modulated
by the amount of compact myelin. Taken together, these results
indicate that formation of compact myelin is required for matura-
tion of the neuronal cytoskeleton in large neurons of the CNS.
MATERIALS AND METHODS
All chemicals used were American Chemical Society quality or better
and were obtained from Sigma (St. Louis, MO), Calbiochem (La Jolla,
CA), or Polysciences (Warrington, PA). Shiverer and MBP/MBP Shiv-
erer transgenic mice (Male and female, 4–6 weeks old, from the colony
maintained by Carol Readhead, Cedars Sinai Medical Center, Los
Angeles, CA) were used for all experiments. Age-matched wild-type
mice (B6C3/F1) were obtained from The Jackson Laboratory (Bar
Harbor, ME). Because shiverer mice are not hardy, all mice were housed
in a sterile environment and were fed sterile food and water throughout
the experiments.
Axonal transport labeling and analysis. Proteins in axonal transport were
labeled in mouse optic nerve by intravitreal injection of 0.5 mCi [ 35S]me-
thionine (Trans 35S Label; ICN Biochemicals, Costa Mesa, CA) into the
right eye as described previously (Brady, 1985). Injections were made
with a 30 gauge needle connected to a Hamilton syringe by a length of
PE20 tubing. Injection-sacrifice intervals (ISIs) were chosen to catch the
peak of the slow component a (SCa) or slow component b (SCb) wave in
the optic nerve and tract. ISIs used were 4–7 d for SCb, and 18, 21, and
24 d for SCa. Two to five mice were analyzed at each time point. Mice
were euthanized under anesthesia, then the optic nerve and tract were
dissected.
The nerve and tract were cut into 1 mm long segments, and each
segment was homogenized individually in 200 ml BUST (2%
b-mercaptoethanol, 8 M urea, 1% SDS, 0.1 M Tris, and 0.02% phenol
red). A 5 ml aliquot of each homogenate was counted in a liquid
scintillation counter, and equal aliquots of each segment were separated
by SDS-PAGE on 4–16% (0–6 M urea) gradient gels. The gels were
stained with Coomassie blue and destained, then processed for fluorog-
raphy by dehydration in dimethylsulfoxide (DMSO; 2 3 30 min), im-
pregnation with diphenyl oxazole (22% in DMSO, 3 hr) and rehydration
(Laskey and Mills, 1975). The gels were then dried and exposed to
preflashed x-ray film (Eastman Kodak, Rochester, NY) for the appro-
priate time. The amount of radioactivity incorporated into specific pro-
teins was quantitated by excising the appropriate bands from the gel
using the fluorograph as a template. The bands were solubilized in 30%
hydrogen peroxide for 2 d at 60°C and counted in a liquid scintillation
counter. In some cases, the fluorograph was analyzed by laser densitom-
etry (Molecular Dynamics, Sunnyvale, CA).
To permit comparison of transport for individual proteins down the
optic nerve in different animals, the total radioactivity in segments was
summed, and then the segment containing the 50% point of radioactivity
was determined (Hoffman et al., 1983). The distance of the 50% point
from cell bodies was then divided by the ISI to determine the rate of
movement. Data for all SCa or SCb time points were averaged, and
statistical significance for differences between rates was determined by a
two-sample t test using DataDesk software. Data are expressed as the
mean 6 SEM.
Quantitative immunoblots. Nerve segments were homogenized in SUB
buffer (0.5% SDS, 8 M urea, and 2% b-mercaptoethanol), then electro-
phoresed on 0.75-mm-thick 6% polyacrylamide gels essentially as de-
scribed previously (Cole et al., 1994). Each lane was loaded with ;10 mg
of nerve protein. Levels of neurofilament subunits were analyzed by
quantitative immunoblots.
After electrophoresis, proteins were transferred to nitrocellulose and
probed with a monoclonal antibody specific for a highly phosphorylated
neurofilament H (NFH) epitope, RM024, which has been previously
characterized (Lee et al., 1986, 1987). To quantitate levels of different
NF epitopes, immunoblots were washed five times for 3 min each in GB
buffer (50 mM triethanolamine, 0.5% Triton X-100, 0.1 M NaCl, 2 mM
K-EDTA, and 0.1% SDS, pH 7.5) and once in PTX buffer (10 mM
NaPO4, pH 7.5, 0.2% Triton X-100, 0.15 M NaCl, and 1 mM EGTA).
Blots were then incubated at room temperature in 125I-goat anti-mouse
IgG (2 3 10 6 dpm/ml) in PTX buffer supplemented with 4% bovine
serum albumin. After incubation, immunoblots were washed again five
times for 3 min in GB buffer. Finally, blots were exposed to a Phospho-
rImager phosphor screen, the screens were digitized on a PhosphorIm-
ager, and radioactive bands were analyzed using the ImageQuant soft-
ware (Molecular Dynamics, Sunnyvale, CA). The amount of
immunoreactivity was evaluated by comparing shiverer, MBP/MBP
transgenic, and wild-type samples on the same blot.
Northern analyses. An NFH-specific probe was obtained using PCR
with forward (GCTGAAGCCAAATCTCCAGCTAC) and reverse
(AGGACTTTCACCTGCTCAGGG) primers directed against the
C-terminal KSP repeat region of NFH. A 15 kb genomic fragment (a gift
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of Dr. Jean-Pierre Julien, McGill University, Montreal, Quebec, Can-
ada) was used as a starting template with primers. A 612 bp NFH probe
was generated using 30 cycles with 45 sec at 94°C, 1 min at 61°C, and 1
min 30 sec at 73°C. A neurofilament M (NFM) probe was made by
amplifying a 355 nucleotide product from a 0.66 kb NFM cDNA frag-
ment originally cloned by Dr. Jean-Pierre Julien subcloned into a pUC8
vector. Forward and reverse primers were, respectively: CAGGATCTC-
CTTAACGTCAAGATGG and TTTCGGCTTCTGGTTCCTCCTC.
The NFM probe was generated using 30 cycles with 45 sec at 94°C, 1 min
at 58°C, and 1 min 30 sec at 73°C with 3 mM MgCl2. A 486 bp neuro-
filament L (NFL) probe was generated from a 1.2 kb NFL cDNA
originally cloned by Dr. Nicolas Cowan inserted in puC8. Conditions
used were similar to those used for the NFM probe, except that the
reaction mix used 7 mM MgCl2. TCAGTTTCACCAGCGTGGGTAG
was the forward primer, and TGATGAGGTTGACCTGATTGGG was
the reverse primer. A GAPDH oligomer with sequence
CAGGGGGGCTAAGCAGTTGGTGGTGCAGGATGCATTGCTG
was used to control for load. PCR products were labeled to a specific
activity of 2–2.5 3 10 9 dpm/mg using a-[ 32P]dCTP (3000 Ci/mmol;
Amersham, Arlington Heights, IL) and a random nonamer kit (Read-
iprime; Amersham). Oligomers were labeled to a specific activity of
2.5–2.9 3 10 9 dpm/mg in a T4 kinase end labeling reaction.
Total RNA was isolated from mouse cortex using standard protocols
for guanidinium extraction as described previously (Chomczynski and
Sacchi, 1987). Five micrograms of total RNA from each animal were run
on a 1% agarose-formaldehyde denaturing gel and transferred to a nylon
membrane (Nytran; Schleicher & Schuell, Keene, NH) in 20 3 SSC.
RNA was UV-crosslinked to the membrane at 150 mJ. Membranes were
fixed in 5% acetic acid, stained in methylene blue, and rinsed in DEPC-
treated water to assess RNA transfer. To prevent probe cross reaction,
blot lanes were cut into two sections: one for the neurofilament-specific
probe and one for loading control. Each was prehybridized at 65°C for a
minimum of 2 hr in buffer containing 53 SSPE, 53 Denhardt’s solution,
0.5% SDS, and 20 mg/ml sheared herring sperm DNA. Blots were
incubated overnight at 65°C with 2 3 10 6 cpm/ml 32P-labeled probes,
washed to a final stringency of 23 SSC, 0.2% SDS at room temperature,
and exposed on a PhosphorImager (Molecular Dynamics) screen. Rela-
tive amounts of neurofilaments were calculated by determining the ratio
of the intensity of the neurofilament and GAPDH signals after back-
ground subtraction.
Electron microscopy and morphometry of mouse optic nerve. Optic
nerves were processed for electron microscopy essentially as described
previously for sciatic nerves (de Waegh et al., 1992). Anesthetized mice
were euthanized. Optic nerves were immediately removed, cut into 1–2
mm segments, and placed into freshly made fixative (2% paraformalde-
hyde, 2% glutaraldehyde in cacodylate buffer, pH 7.2, 37°C). After 2–3 hr
of initial fixation, nerve segments were placed in fresh fixative overnight
at 4°C. The nerves were post-fixed with 1% osmium tetroxide, dehy-
drated, and embedded in Epon. Thin sections were cut, counterstained
with uranyl acetate and lead citrate, and viewed with a JEOL 1200SX
electron microscope. Axons cut in cross-section were photographed at
50,0003.
Neurofilament and microtubule densities were quantitatively evaluated
in Shiverer, MBP/MBP transgenic, and wild-type mouse optic nerve
axons as described previously (Price et al., 1988; de Waegh and Brady,
1991; de Waegh et al., 1992). Briefly, a transparency with evenly spaced
hexagons was placed over electron micrographs printed at a final mag-
nification of 140,0003. At this magnification, each hexagon represents
0.035 mm 2 of axoplasm. All hexagons for which .90% of their area was
within axonal boundaries, membrane-bounded organelles occupied
,10% of the space, and the neurofilaments and microtubules cut in true
cross-section were used. The number of neurofilaments or microtubules
present in each of the suitable hexagons was counted. At least 60 axons
(370 hexagons) were counted for each mouse type. The average number
of neurofilaments or microtubules per hexagon was calculated by dividing
the total number counted by the total number of hexagons. Additionally,
the number of myelin wraps was noted for each axon counted. All values
are expressed 6 SEM. Significant differences were determined by a
two-sample t test using Data Desk software.
RESULTS
Cytoskeletal proteins of the axon are moved with one of the slow
axonal transport rate components: tubulin and neurofilament
proteins move in SCa, whereas some tubulin and actin move in
SCb (Brady, 1993). Measurement of slow axonal transport in
demyelinated PNS fibers of Trembler mice found a transport rate
for cytoskeletal proteins significantly slower than wild-type con-
trols. To determine whether CNS myelin affected transport of
cytoskeletal proteins similarly, transport rates were analyzed in
optic nerves and tracts of shiverer, MBP/MBP transgenic, and
wild-type mice as described previously (Brady, 1985). Briefly, 0.5
mCi [ 35S]methionine was injected into the vitreous of the eye to
pulse label proteins synthesized in retinal ganglion cells. At
various intervals after labeling, the optic nerve and tract were
dissected and cut into 1 mm segments for gel electrophoresis.
Radioactive polypeptides in each nerve segment were visualized
by fluorography (Fig. 1A) and fluorographs used to estimate rates
of transport for cytoskeletal proteins: measuring neurofilament
and microtubule protein distribution for SCa and measuring actin
distribution for SCb.
Although rates for neurofilament transport in SCa were slower
in Trembler sciatic nerve, labeled neurofilament subunits had
moved further along shiverer nerves than along control nerves at
the same time point (Fig. 1A), indicating a faster rate of trans-
Figure 1. SCa and SCb rates are increased in shiverer relative to control
and MBP/MBP shiverer transgenic rates. A, Slow axonal transport rates
were examined by segmental analysis. [ 35S]methionine was injected into
the vitreous of the mouse eye, and 21 d after injection, optic nerve and
tracts were harvested and cut into 1 mm segments. Radioactively labeled
proteins in each segment were resolved on SDS-PAGE gels, processed for
fluorography, and exposed to film. Fluorographs of control, MBP/MBP
shiverer transgenic, and shiverer animals show the wave of radioactively
labeled SCa proteins traveling down the optic nerve and tract. The
positions for neurofilament subunits (H, M, and L) and tubulin doublet
(T) are distributed as a wave in all three animals 21 d after injection. Note
that the peaks for NFH and NFM are in axon segments 3–4 mm for
control and MBP/MBP nerves, but are in segments 5–6 mm for shiverer.
Similarly, the peak of tubulin is 4 mm in control and MBP/MBP shiverer
transgenic animals but 5.5 mm in shiverer animals. Note that NFH is
barely detectable in shiverer and MBP/MBP animals when compared to
control, but NFL levels are comparable. B, Distance from retina for
labeled peaks of actin at 4, 5, and 7 (actin) and for NFM at 18, 21, and
24 d after labeling. Data are plotted for shiverer (triangles), MBP/MBP
transgenics (circles), and wild-type control ( filled squares), where each
symbol is data from a different animal, and two to five animals were used
for each time point. A best fit line passing through zero is shown for
shiverer (short dashed line, triangle), MBP/MBP transgenic (long dashed
line, circle), and wild-type control (solid line, filled square). The slope of
this line represents the rate of slow transport.
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port. Similar changes were seen for distribution of tubulin in SCa
(Fig. 1A) and for actin and various other SCb proteins (including
spectrin and clathrin; data not shown). In contrast to the shiverer,
distributions of labeled cytoskeletal proteins in MBP/MBP trans-
genic nerves were the same as wild-type for all proteins examined
(Fig. 1A), indicating that the formation of compact myelin was
sufficient to alter slow axonal transport rates even when myelin
thickness was only 25% of normal.
Rates of transport for actin and NFM may be estimated by
plotting the distance of their labeled peaks at 4, 5, and 7 (actin)
or 18, 21, and 24 d (NFM) after labeling (Fig. 1B), where the
slope of the line corresponds to the rate. For both actin and NFM,
the slope was greatest for the shiverer nerves, whereas wild-type
and MBP/MBP slopes were almost the same. Alternatively, rates
of transport may be calculated by measuring how far 50% of the
labeled protein had moved at each time point (Table 1). By this
measure, NFM moved at 0.20 6 0.02 mm/d in shiverer, which was
significantly different ( p # 0.05 using a two-sample t test) from
the rate of 0.17 6 0.03 mm/d seen in both wild-type and MBP/
MBP. Similarly, actin and spectrin moved at ;0.95 mm/d in
shiverer nerves, but only 0.75–0.85 mm/d in wild-type and MBP/
MBP nerves (Table 1). The fact that even reduced levels of
compact myelin were sufficient to restore axonal transport to near
wild-type is consistent with observations on suppression of
tremor and extension of life span in the transgenic (Readhead et
al., 1987).
A different impression emerged from electron microscopic
analysis of nerves on these three types of mouse. Figure 2 shows
axonal cross sections from the optic nerve of wild-type (A, B),
MBP/MBP transgenic (C, D), and shiverer (E, F) mice. The
absence of compact myelin in shiverer is apparent, although
oligodendrocyte processes can be seen to wrap each axon. By
comparison, MBP/MBP nerves typically have only a few lamellae
of compact myelin, much reduced relative that seen in control
nerves. However, even qualitative examination of cytoskeletal
elements in the axons indicate that shiverer and MBP/MBP fibers
resemble each other far more than either resembles wild-type
fibers. Microtubules are much more abundant than in wild-type
Table 1. Slow axonal transport rates for neurofilament and microfilament subunits in shiverer, MBP/MBP shiverer transgenic, and wild-type mouse
optic nerve (rates in millimeters per day)
Shiverer MBP/MBP Wild-type
SCa: Neurofilament protein (NFM) 0.20 6 0.02a n 5 5 0.17 6 0.03 n 5 8 0.17 6 0.03 n 5 6
SCb: Actin 0.95 6 0.07b n 5 4 0.83 6 0.07 n 5 6 0.86 6 0.13 n 5 7
SCb: Spectrin 0.96 6 0.08c n 5 4 0.74 6 0.11 n 5 6 0.82 6 0.12 n 5 7
The average distance travelled by 50% of the label associated with marker proteins for SCa and SCb was determined by cutting specific molecular weight bands out of the
fluorographs (Fig. 1A) and counting the amount of radioactivity incorporated into each protein. Rates of travel were calculated by dividing the distance by the time between
radiolabel injection and the sacrifice of the animal (4, 5, and 7 d for SCb proteins and 18, 21, or 24 d for SCa proteins). Data is expressed as the mean 6 SEM.
aShiverer NFM rate significantly different from MBP/MBP rate at p 5 0.03 and from wild-type at p 5 0.05.
bShiverer actin rate significantly different from MBP/MBP rate at p 5 0.05.
cShiverer spectrin rate significantly different from MBP/MBP rate at p 5 0.008 and from wild-type at p 5 0.03.
Figure 2. Axonal neurofilament and microtubule organization and numbers are altered in MBP/MBP shiverer transgenic and shiverer optic axons
relative to control. Typical axonal cytoskeletons are shown in electron micrographs of optic nerve axonal cross sections from wild-type (A, B), MBP/MBP
transgenic (C, D), and shiverer (E, F ) mice. The number and density of microtubules (arrow) are significantly increased in MBP/MBP transgenic and
shiverer axons relative to wild-type control axons. Neurofilament organization (arrowhead) appears altered to produce increased density, although these
changes are less dramatic than those seen with microtubules. Neurofilament numbers may be depressed in the shiverer and MBP/MBP transgenic axons.
Compare the completely myelinated axons in control to the partially myelinated axons of MBP/MBP shiverer transgenic animals and unmyelinated axons
of shiverer. Although the density of extracellular material appears similar in micrographs from each category of mouse, the electron density of axoplasm
appears greatest in MBP/MBP transgenics and is also increased in shiverer axons. Scale bar, 0.19 mm.
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and appear closer to each other, whereas the axoplasm of both
shiverer and MBP/MBP fibers has an increased electron density.
Differences in axonal microtubules and neurofilaments were
even more striking in quantitative morphometric analyses. The
similarities between shiverer and MBP/MBP mice are readily
seen in the density distribution of microtubules in optic axons of
shiverer, MBP/MBP, and wild-type mice (Fig. 3A). The mean
number of microtubules per unit hexagon in shiverer was 4.4 and
in MBP/MBP was 4.5. Each of these was significantly different
from the mean of 1.9 microtubules per hexagon for wild-type
axons with a p # 0.0001 using a two-sample t test. These values
indicate that axons in shiverer and MBP/MBP nerves averaged
;20–21 microtubules per axon, whereas wild-type axons aver-
aged only 10–11 microtubules per axon.
Differences in neurofilament density could also be seen (Fig.
3B), but in this case MBP/MBP neurofilament densities were
intermediate between those of shiverer and wild-type. The mean
number of neurofilaments per unit hexagon in shiverer (6 SEM)
was 4.85 6 0.06 and in MBP/MBP was 4.63 6 0.05, as opposed to
a mean of 4.11 6 0.05 neurofilaments per hexagon in wild-type
axons. The mean of shiverer neurofilaments per hexagon was
significantly different from both wild-type and transgenic with a
p # 0.0001 in a paired t test, whereas the difference between
wild-type and MBP/MBP was significant at p # 0.002. As previ-
ously seen in the PNS with Trembler, neurofilament density
increases in the absence of compact myelin. In contrast to the
large increase in numbers of microtubules per axon, numbers of
neurofilaments per axon were slightly depressed in shiverer axons
with an average of 34–35 neurofilaments per axon in shiverer,
39–40 neurofilaments per axon in MBP/MBP, and 43–44 neuro-
filaments per axon in wild-type axons.
The axonal transport experiments (Fig. 1A) not only showed an
increased rate of transport for neurofilaments in shiverer, but also
suggested that neurofilament subunit composition was altered.
When the amount of radiolabel associated with each subunit was
expressed as a fraction of total radiolabeled SCa proteins in optic
nerve (Fig. 4A), the relative amount of NFH was reduced in
shiverer and transgenics. The mean level of NFH was essentially
the same in shiverer and MBP/MBP transgenics. However, the
difference between transgenics and wild-type was significant at
p 5 0.037 using a two-sample t test, whereas the difference
between shiverer and wild-type was significant only at p 5 0.051
because of the greater scatter in data from shiverer. In contrast,
relative amounts of NFM were reduced in shiverer nerves rela-
tive to both wild-type and MBP/MBP transgenics (differences
were significant at p 5 0.035 and p # 0.0001, respectively in a
two-sample t test). NFM protein levels in MBP/MBP nerves were
actually elevated over wild-type levels (difference significant at
p 5 0.04 in a two-sample t test). Although higher molecular
weight subunits were decreased in shiverer, NFL levels were
slightly but significantly elevated in shiverer nerves over both
wild-type ( p 5 0.026) and MBP/MBP ( p # 0.013, both using a
two-sample t test). Based on a similar analysis, amounts of tubulin
protein present in shiverer and MBP/MBP nerves were also
significantly increased over wild-type (L. L. Kirkpatrick, A. S.
Witt, C. Readhead, and S. T. Brady, in preparation).
These values may be used to calculate the relative contribution
of each subunit to total neurofilament mass in the three mouse
strains (Fig. 4B). NFH represented only 8% of the mass for
shiverer and MBP/MBP neurofilaments, but comprised 12% of
wild-type neurofilaments. Increased NFM levels in MBP/MBP
nerves mean that NFM constituted a greater fraction of the
neurofilaments in transgenic nerves (33%) than of those in either
shiverer (20%) or wild-type (27%). Similarly, shiverer neurofila-
ments included a greater proportion of NFL (73%), whereas the
contribution of NFL to MBP/MBP and wild-type was compara-
ble (59 and 61%, respectively).
Differences in cytoskeletal protein levels seen in shiverer and
MBP/MBP nerves could have been caused by changes in either
cytoskeletal gene expression or protein degradation. When levels
of NFH and NFM mRNA were analyzed by Northern blot
Figure 3. Morphometric analyses show changes for both microtubule and
neurofilament density in shiverer and MBP/MBP shiverer transgenic
axons. As a measure of cytoskeletal organization, the density of micro-
tubules and neurofilaments was examined as described previously (de
Waegh et al., 1992). The number of cytoskeletal elements in random
hexagons was evaluated. Both microtubules and neurofilament densities
are shifted to higher values in shiverer axons. A, Microtubule distributions
were similar in shiverer and MBP/MBP transgenic nerves. The mean
number of microtubules per hexagon was increased in both MBP/MBP
transgenic (4.38 6 0.05; 6 SEM) and shiverer (4.53 6 0.05; 6 SEM)
axons. These differences were significant at p # 0.0001 (two-sample t test)
when compared to the wild-type control value of 1.9 6 0.07 (6 SEM) MT
per hexagon. B, Unlike microtubules, the neurofilament distribution in
MBP/MBP transgenic nerves was intermediate between shiverer and
wild-type control nerves. The mean number of neurofilaments per hexa-
gon was also significantly greater in shiverer (4.39 6 0.06; 6 SEM
neurofilaments per hexagon) and MBP/MBP shiverer transgenic (4.75 6
0.05; 6 SEM neurofilaments per hexagon; in a paired t test relative to
wild-type control) than in control (4.11 6 0.05 neurofilaments per hexa-
gon). Differences relative to wild-type control axons are significant at p #
0.0001 (shiverer) and p 5 0.002 (MBP/MBP transgenic) in a paired t test.
Morphometric analyses were conducted by overlaying a hexagonal grid
over electron micrographs of the optic axonal cross sections printed at a
final magnification of 140,0003. Each hexagon represented an area of
0.035 mm 2. The number of microtubules and neurofilaments per hexagon
was scored, binned, and plotted. The number of microtubules per hexagon
ranged between 0 and 12, whereas the number of neurofilaments per
hexagon ranged from 0 to 23.
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analyses of total RNA fractions from shiverer, MBP/MBP, and
wild-type CNS tissue (Fig. 5), striking differences were seen. A
probe specific for NFH recognized a 4.0 kb message, and the
same blots were analyzed with a GAPDH probe to allow normal-
ization for RNA load (Fig. 5A). When expressed as a ratio to
wild-type levels, shiverer NFH mRNA levels were significantly
reduced ( p 5 0.029 using a paired t test) (Fig. 5B). The mean
level of NFH message in MBP/MBP tissue was also reduced (Fig.
5B), but the observed differences were not statistically significant
at the p # 0.05 level (n 5 5). These results indicate that either
transcription or stability of NFH mRNA is sensitive to the level
of myelination.
Although NFM protein levels were depressed in shiverer and
slightly elevated in MBP/MBP, parallel analyses of the 3.5 kb
NFM message showed a different pattern for NFM mRNA ex-
pression quite different from that seen for NFH (Fig. 5C). After
normalizing for RNA load by comparison with GAPDH, levels of
NFM message in the CNS (Fig. 5D) were essentially the same as
wild-type for both MBP/MBP (1.09 6 0.05) and shiverer (1.15 6
0.07). The slight increases were not statistically significant at p #
0.05 using a paired t test (n 5 11). These results suggest that
either translation of NFM mRNA or the stability of NFM protein
is sensitive to the level of myelination.
Because phosphorylation of neurofilaments in Trembler pe-
ripheral nerves is significantly reduced in demyelinated regions,
we used antibodies sensitive to phosphorylation state of NFH in
quantitative immunoblots. After compensating for differences in
NFH protein levels by normalizing signals to wild-type levels, the
level of relative phosphorylation for NFH could be examined in
the corpus callosum and sciatic nerve of MBP/MBP and shiverer
mice based on immunoreactivity with the RMO24 monoclonal
antibody, which recognizes only highly phosphorylated NFH
(Lee et al., 1986). NFH phosphorylation was reduced in CNS
axons of the corpus callosum, but was unaffected in PNS axons of
the sciatic nerve (Fig. 6). The differences from wild-type control
values in CNS tissue were significant using a paired t test for both
shiverer ( p 5 0.016) and MBP/MBP transgenics ( p 5 0.0014).
These results indicate that deficient myelination locally reduces
neurofilament phosphorylation in both CNS (shiverer and MBP/
MBP) and PNS (Trembler; de Waegh et al., 1992) fibers. Notably,
the suboptimal CNS myelination seen in MBP/MBP transgenics
was not sufficient to restore neurofilament phosphorylation to
Figure 4. Neurofilament protein levels and neurofilament composition
are changed in MBP/MBP shiverer transgenic and shiverer animals
relative to control. The amount of NFH, NFM, and NFL protein in
nerves expressed as a fraction of the total protein moving with SCa was
determined by densitometry of fluorographs from axonal transport studies
in wild-type control, MBP/MBP transgenic, and shiverer mice. A, NFH
protein levels are decreased relative to wild-type control in both MBP/
MBP transgenic and shiverer (n 5 17; n 5 24; and n 5 17, respectively).
The differences in NFH for shiverer was different from wild-type at p 5
0.051, whereas MBP/MBP transgenics were different at p 5 0.037. Shiv-
erer and transgenics had a similar mean value for NFH, but the shiverer
data had greater scatter. NFM levels were decreased in shiverer mice
relative to both wild-type ( p 5 0.035) and transgenics ( p # 0.0001), but
NFM in MBP/MBP transgenic animals was increased over wild-type
( p 5 0.04). NFL levels were not distinguishable between wild-type
control and MBP/MBP transgenics, but were increased slightly in shiverer
relative to both wild-type control ( p 5 0.026) and MBP/MBP transgenics
(difference significant at p # 0.0001). All comparisons were made using a
two-sample t test. B, Changes in the relative contributions of NFH, NFM,
and NFL proteins to neurofilament mass illustrate changes in composi-
tion. A larger proportion of shiverer neurofilament consists of NFL
subunits, whereas in control animals the contribution of NFH to the
neurofilament mass is greater than either MBP/MBP transgenic or shiv-
erer neurofilaments. Similarly, in MBP/MBP shiverer transgenic the
contribution of NFH to neurofilament mass is comparable to that in
shiverer, but the NFM content is greater than in either control or shiverer
animals.
Figure 5. Expression levels of NFH are significantly reduced in shiverer
as opposed to wild-type control. The reduced levels of NFH polypeptide
in shiverer and MBP/MBP transgenic is reflected in reduced levels of
NFH mRNA. In contrast, NFM mRNA is not significantly different from
wild-type control in either shiverer or MBP/MBP transgenic animals. A,
Northern blot of NFH and the GAPDH loading control. The expression
of the 4.0 kb NFH transcript appeared to be reduced in shiverer when
compared to control or MBP/MBP transgenic animals. The NFH mRNA
levels in MBP/MBP transgenic appeared to be slightly reduced. Each lane
contains 5 mg of total RNA isolated from the cortices of age-matched
animals. B, Quantitation of the NFH expression levels (n 5 5). After
normalizing with GAPDH, a ratio of NFH expression was calculated, and
the expression level of shiverer and MBP/MBP shiverer transgenic was
normalized to control expression levels. The levels of NFH expression
were significantly reduced in shiverer relative to control ( p 5 0.029 in a
paired t test). Although levels of NFH expression in MBP/MBP shiverer
transgenic animals were consistently reduced as opposed to wild-type
control and consistently higher than shiverer NFH expression levels, the
differences were not significant at p $ 0.05. C, Northern blot of NFM and
GAPDH loading control. No consistent differences in mRNA expression
levels were apparent. D, Quantitation of relative NFM levels in the three
animals (n 5 11). NFM levels were not significantly different in the three
animal types.
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normal levels. In the Trembler mouse, graft studies demonstrated
that differences in phosphorylation of neurofilaments was caused
by differences in local activity (de Waegh and Brady, 1991).
Although a similar mechanism may well be operational in shiv-
erer axons, the observed effects of myelination on neuronal gene
expression raise the possibility that altered neurofilament phos-
phorylation shiverer axons could be caused by changes in the
expression of kinases or phosphatases. Because similar graft
studies are not currently feasible in the CNS, resolution of this
issue will require alternative approaches.
In summary, a wide range of axonal and neuronal parameters
were altered in the CNS of myelin-deficient shiverer mice, in-
cluding rates of axonal transport, organization, and composition
of the axonal cytoskeleton, posttranslational modification of cy-
toskeletal proteins, and cytoskeletal gene expression in the neu-
ronal cell body. The reduced level of myelination found in the
MBP/MBP transgenic mouse was sufficient to restore some pa-
rameters to wild-type levels (slow axonal transport rates and
NFM protein levels), but not sufficient to restore others (such as
microtubule numbers and NFH protein levels). Despite these
alterations in the composition and architecture of CNS axons in
the MBP/MBP transgenic mouse, the reduced level of myelina-
tion in transgenics was sufficient to restore normal life span and
minimize tremors.
DISCUSSION
The effects of demyelination on the PNS axonal cytoskeleton in
Trembler mutant mice (de Waegh and Brady, 1990; de Waegh,
1990; de Waegh and Brady, 1991) led to examination of similar
parameters in optic axons of CNS myelin-deficient shiverer mu-
tant mice. Shiverer mice lack myelin basic protein, an essential
structural component of CNS myelin (Campagnoni and Macklin,
1988) and do not form CNS compact myelin. Many of the same
parameters were altered in both shiverer and Trembler axons
without myelin, but these changes were not always in the same
direction, and additional characteristics were affected in shiverer
myelin-deficient neurons. Because transgenic mice homozygous
for an MBP transgene in a shiverer background have myelin
sheaths significantly thinner than wild-type, the requirement for a
myelin sheath of normal thickness was assessed in parallel studies.
Surprisingly, some neuronal parameters were restored to wild-
type values by a thin myelin sheath, whereas others were more
like shiverer or intermediate between the two. Characteristics of
neurons in both shiverer and MBP/MBP transgenic mice are
reminiscent of immature or unmyelinated axons, suggesting that
myelinating glia play a role in differentiation of neurons with large
axons.
Shiverer is a CNS myelin deficiency mouse mutant (Chernoff,
1981) resulting from a recombination within the MBP gene
(Roach et al., 1985; Molineaux et al., 1986) that eliminates MBP
expression (Roach et al., 1983; Kimura et al., 1985). Although
MBP is normally present in PNS myelin, PNS myelination is near
normal in MBP null mice (Rosenbluth, 1980), because PNS-
specific proteins with overlapping function exist. However, dif-
ferences do exist in shiverer PNS myelin fine structure, including
mild hypomyelination and a significant increase in Schmidt-
Lantermann cleft number (Gould et al., 1995). In contrast, MBP
null mice have no compact myelin in their CNS (Shine et al.,
1992). Absence of CNS myelination in shiverer leads to severe
intention tremor and early death, typically within 100 d (Read-
head and Hood, 1990). Although shiverer is the best character-
ized animal model with deficits in MBP expression, less severe
alleles like shimld/shimld (myelin deficient) mouse exist (Read-
head and Hood, 1990), and transgenic mice have been generated
that express varying levels of MBP (Popko et al., 1987; Readhead
et al., 1987; Kimura et al., 1989). Availability of mouse models
with different levels of MBP expression permits detailed analyses
of myelination effects on CNS function (Popko et al., 1987; Shine
et al., 1992).
Introduction of MBP transgenes into shiverer was the first
genetic “cure” of a neurological mutant (Readhead et al., 1987).
Shiverer mice homozygous for an MBP transgene have MBP
mRNA and protein levels ;25% of normal (Popko et al., 1987;
Readhead et al., 1987). MBP/MBP transgenics produce compact
myelin with morphologically normal major dense lines, but sub-
stantially reduced myelin sheath thickness. Optic axons typically
have only two to four lamellae as opposed to 8–11 or more
lamellae in wild-type. Even this modest investiture of compact
myelin was sufficient to restore life spans of MBP/MBP mice to
wild-type values and largely suppress intention tremor (Readhead
et al., 1987). This showed that essential aspects of neuronal
Figure 6. Quantitative immunoblot analysis of highly phosphorylated
NFH antibody immunoreactivity in corpus callosum and sciatic nerve
homogenates from MBP/MBP shiverer transgenic and shiverer relative to
wild-type control. The relative phosphorylation of NFH was significantly
reduced in CNS, but not in PNS axons. Whereas NFH levels were
reduced in the CNS of MBP/MBP transgenic and shiverer mice, the
phosphorylation of the NFH present was roughly half that of wild-type
controls. The differences from wild-type control values were significant at
p 5 016 for shiverer and at p 5 0.0014 for MBP/MBP transgenics.
Phosphorylation of NFH was not significantly different between MBP/
MBP transgenic and shiverer nerves. Approximately 10 mg of corpus
callosum or sciatic nerve homogenates was run on SDS-PAGE gels and
transferred to nitrocellulose blots, then blotted with the RMO24 antibody,
which is specific to highly phosphorylated NFH. This was followed by a
radioactively labeled secondary antibody before being exposed to a Phos-
phorImager screen. The relative intensity of highly phosphorylated NFH
immunoreactivity on the ensuing scans was determined. Highly phosphor-
ylated NFH signals were normalized to NFL-immunoreactive signals
that had been corrected for varying levels among the three animal types
using the data in Figure 4. Each was plotted as the ratio of NFH-
immunoreactive signal from MBP/MBP or shiverer to control. All values
were corrected for the varying amounts of NFH protein levels among the
three animal types using the data in Figure 4 before calculation of
phosphorylation ratios. For corpus callosum samples, n 5 32 for shiverer
animals, n 5 21 for MBP/MBP animals, and n 5 17 for control animals.
For sciatic nerve samples, n 5 32 for shiverer, n 5 20 for MBP/MBP, and
n 5 18 for control animals.
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function can be reestablished by minimal myelination and was
consistent with observations that even a thin myelin sheath allows
saltatory conduction of action potentials (Shrager and Rubin-
stein, 1990). Initial observations on slow axonal transport rates
reinforced this conclusion, because rates of transport in MBP/
MBP optic nerves were indistinguishable from wild-type (Fig. 1).
Although normal axonal transport rates, minimal tremor, and
normal life span of MBP/MBP mice all implied that any amount
of compact myelin would restore axonal functionality, electron
micrographs of optic nerves from shiverer, MBP/MBP, and wild-
type mice (Fig. 2) led to a very different conclusion about axonal
morphology. Differences between wild-type and MBP/MBP ax-
ons in ultrastructure, cytoskeletal organization, and cytoskeletal
composition are as apparent as similarities between shiverer and
MBP/MBP axons. Differences in organization were confirmed by
morphometric studies and prompted quantitative analysis of cy-
toskeletal composition. Neurofilament protein and mRNA levels
were altered in shiverer and MBP/MBP transgenic mouse CNS
tissue. In contrast to Trembler PNS axons where levels of axonal
neurofilament protein did not differ from controls (de Waegh et
al., 1992), interactions between oligodendrocytes and axons dur-
ing compact myelin formation significantly altered axon cytoskel-
etal composition as well as organization.
The shiverer axonal cytoskeleton is similar in many respects to
the cytoskeleton of wild-type axons before myelination. NFH
appears later in development than NFM and NFL (Shaw and
Weber, 1982; Willard and Simon, 1983; Pachter and Liem, 1984),
and rates for SCa and SCb are faster in immature fibers gradually
slowing with maturation and aging (Hoffman et al., 1985). A
significant upregulation of NFH mRNA (Hoffman et al., 1988)
occurs postnatally, and immature neurofilaments have lower con-
tent of the NFH subunit than neurofilaments from adult nerves
(Shaw and Weber, 1982; Pachter and Liem, 1984; Carden et al.,
1987). Upregulation of NFH protein and slowing of slow axonal
transport occur at P10-P20 in rodent optic nerve (Willard and
Simon, 1983; Pachter and Liem, 1984; Carden et al., 1987),
concurrent with myelination of these axons. The failure of shiv-
erer to produce a mature CNS axonal cytoskeleton in combina-
tion with temporal correlation of maturation in wild-type devel-
opment strongly suggests that formation of compact myelin is
necessary for normal differentiation of neurons with large axons.
This conclusion is strengthened by the intermediate phenotype
seen with MBP/MBP axons (slower transport and higher NFM
expression, whereas NFH expression continues to be altered; see
Table 2 for summary of changes).
Altered cytoskeletal gene expression in shiverer and MBP/
MBP indicated that signaling pathway or pathways exist by which
myelinating glia influence CNS neuronal differentiation. Al-
though some components of these pathways modify local prop-
erties of CNS axons like neurofilament phosphorylation, others
affect events in the neuronal cell body. Changes in the neuronal
perikaryon include altered levels of NFH mRNA presumably
through effects on transcriptional regulation and changes in net
translation of NFM mRNA. A previous report (Sanchez et al.,
1996) suggested that oligodendrocyte influence on axonal caliber
required contact, but not formation of compact myelin. However,
this study focused on retinal ganglion cell axon segments as they
emerge from the lamina cribosa. This is a transitional myelination
region and is not representative of mature myelinated fibers.
Regardless, data presented here demonstrate that simple contact
between oligodendrocyte and axon is not sufficient.
Signaling pathways by which oligodendrocytes influence neu-
rons remain to be determined. However, some characteristics of
these pathways can be defined (Fig. 7). A locally acting compo-
nent must affect specifically axonal kinase/phosphatase activities
to produce observed local changes in neurofilament phosphory-
lation. A retrograde signaling component must also exist that is
transported back to neuronal perikarya to influence neuronal
gene expression at the level of translation and/or transcription.
This second component may be generated either directly or
indirectly (by modification of axonal components for return).
Finally, activation of signaling pathways for communication be-
tween myelinating glia and axons must require intimate contacts
associated with formation of compact myelin. This last element
suggests a plausible model might be based on various receptor-
linked kinases that affect gene expression in non-neuronal cells
through phosphorylation cascades modifying transcription factors
and other cellular targets.
While the transgenic shiverer mouse was termed a genetic
rescue based on increased life span and suppression of tremor
(Readhead et al., 1987), detailed analyses of axonal composition
and morphology reveal a more complex situation (Table 2). Some
features of transgenic axons like slow axonal transport and NFM
expression are comparable to wild-type, but other parameters like
expression of tubulin and NFH subunits remain more like shiv-
erer (Figs. 1, 4, 5). Other parameters like neurofilament density
are intermediate between shiverer and wild-type. This suggests
that multiple pathways exist by which myelinating glia influence
neuron and axons. Some characteristics are restored by formation
of a thin myelin sheath such as that found in transgenic shiverers,
but others are not activated until a thicker myelin sheath such as
that found in wild-type has formed. While the genetic lesion is
well characterized (Molineaux et al., 1986; Readhead and Hood,
1990), disruption of normal relationships between axon and oli-
godendrocyte may affect other aspects of glial differentiation,
including secretion of regulatory factors and expression of cell
surface proteins. These differences may be the direct cause of
altered neuronal phenotypes in shiverer and transgenic shiverer.
A number of differences exist between demyelinating (Trem-
bler) and dysmyelinating (shiverer) mutants. For example, local
effects on the axonal cytoskeleton are more apparent in Trembler,
but changes in gene expression are more pronounced in shiverer.
This might reflect differences in effects of CNS and PNS myeli-
nating glia on axons. Consistent with this possibility, previous
studies showed that neurons react differently to PNS and CNS
glial environments (Vidal-Saenz et al., 1987; Schwab and Caroni,
1988). Similarly, CNS- and PNS-myelinated fibers differ in ultra-
Table 2. Summary of changes in neuronal parameters for shiverer,
transgenic shiverer, and wild-type mice
Shiverer MBP/MBP Wild-type
Myelin basic protein 0 0.25 1.0
Compact myelin lamellae 0 2–4 .10
Slow axonal transport Increased Normal Normal
Microtubule number 23 increase 23 increase Normal
Microtubule density 23 increase 23 increase Normal
Neurofilament density 1.23 1.13 1.0
NFH expression Decreased Decreased Normal
NFM expression Decreased Slight elevation Normal
Neurofilament
phosphorylation Decreased Decreased Normal
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structure (Peters et al., 1991) and protein composition (Morell et
al., 1994). The extent to which Trembler and shiverer reveal
PNS/CNS differences in axon/glia interactions may help charac-
terize the molecular basis for different axonal responses to PNS
and CNS environments.
However, phenotypic differences between shiverer and Trem-
bler mutants might account for some differences. In Trembler,
compact myelin forms around PNS axons, but does not go to
completion. Instead, myelin is resorbed, and Schwann cells con-
tinue proliferating. In contrast, shiverer CNS neurons never see
compact myelin, whereas MBP/MBP transgenic neurons see lim-
iting amounts of compact myelin. Perhaps the myelination level
achieved before demyelination in Trembler is sufficient to pro-
duce normal expression of neurofilament and tubulin subunits
(but not the microtubule-associated protein tau; see Kirkpatrick
and Brady, 1994, their Fig. 4), whereas myelin levels in MBP/
MBP transgenics are subthreshold. Support for this idea comes
from evidence that mice expressing 50% or more of wild-type
MBP levels have normal myelin sheaths (Shine et al., 1992),
suggesting a threshold level of MBP for myelination exists. Anal-
ysis of axonal cytoskeletal composition and ultrastructure in mice
expressing higher levels of MBP and in mice with a CNS demy-
elination phenotype should distinguish between these two
possibilities.
Differences between MBP/MBP and wild-type axons also in-
dicate that feedback mechanisms must inform neurons about the
extent of myelination. Such pathways would be likely to represent
mechanisms by which myelin sheath thickness is adjusted to axon
caliber (Friede and Miyagishi, 1972). Whereas correlations be-
tween axon caliber and myelin sheath thickness is robust and
adjustments to sheath thickness associated with changes in axon
diameter are well documented, no plausible mechanisms for
counting myelin lamellae have been identified. Analysis of mice
with different MBP levels may illuminate ways by which myelin
sheath thickness is specified.
Functional consequences of altered cytoskeletal composition
and organization in MBP/MBP and shiverer nerves are not well
understood. Partial myelination in MBP/MBP mice produces
normal life spans and grossly normal behavior under laboratory
conditions, but no studies have specifically addressed physiologi-
cal effects of an altered cytoskeleton. Similarities in fine structure
between developing or unmyelinated axons in wild-type mice and
mature shiverer axons suggest that aspects of neuronal physiology
that change during development might be affected. For example,
timing of CNS myelination correlates with the end of critical
periods in neuronal development, suggesting that myelination
may influence developmental stabilization of synaptic connectiv-
ity and neuronal plasticity. One intriguing possibility is that
Figure 7. Pathways for compact myelin to affect CNS neuronal differentiation. Although the molecular identity of many components involved in the
modulation of neuronal architecture by myelinating oligodendrocytes remains to be determined, essential characteristics of these pathways can be
defined. In this diagram, some of these key elements are illustrated schematically. One or more signals is produced by interaction between compact
myelin and axon (small arrows). These signals are not produced by simple interaction between an oligodendrocyte process and the axon, such as is seen
in shiverer (arrows in circle with bar), but require formation of compact myelin. Signals produced in axon segments surrounded by compact myelin suggest
multiple actions. The first may be an action on local factor or factors (eight-pointed star) that changes the net activity of axonal kinases and/or
phosphatases, thereby altering the net phosphorylation state of neurofilaments in that segment, much as was seen in Trembler PNS neurons. In this figure,
the open symbols represent factors in the absence of myelin, whereas the filled symbols correspond to factors that have been “activated” in the presence
of compact myelin. A second action might involve a retrograde acting factor ( filled star) that is committed to retrograde axonal transport and returned
to the cell body. At the level of the cell body, this retrograde signal may activate other pathways, directly alter transcription in the nucleus (stars in nucleus),
or act at the level of translation in the cell body (stars near polysomes). In the absence of appropriate myelination, axonal signals might fail to be activated
(unfilled stars in axon), leading to an altered composition and organization of the axonal cytoskeleton, or may not be returned to the cell body.
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critical periods could be extended in myelin deficiency mutants
yielding altered or unstable synaptic connectivity. Similarly, inhi-
bition of neurite outgrowth by mature oligodendrocytes that
appears during early stages of myelination (Caroni and Schwab,
1989) may be delayed, thereby altering patterns of axonal growth
and regeneration in the CNS. Full delineation of changes in CNS
neurons associated with deficient compact myelin requires fur-
ther study.
In summary, CNS myelin deficiencies lead both to local con-
sequences on the axon cytoskeleton (i.e., reduced neurofilament
phosphorylation) and to altered gene expression in the cell body
(i.e., decreased neurofilament protein). Reduced myelination in
MBP/MBP nerves converts some parameters to match wild-type
completely (transport rates and NFM levels), whereas other pa-
rameters match only partially (NFH message), and others were
indistinguishable from axons without any myelin (microtubule
numbers). Thus, myelination has a profound effect on axonal
cytoskeleton properties and composition, but a partial comple-
ment of myelin is not sufficient to induce a full response from
neurons. Regardless, signals produced during myelination affect
differentiation of neurons with large axons and maturation of
neuronal function. These data demonstrate that the relationship
between neurons and myelinating glia is more complex than
previously thought. Understanding the molecular bases of this
relationship is critical to understanding how nervous systems can
be assembled and maintained.
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